(Q33932479)

30 July 2017

title

Elevated levels of select gangliosides in T cells from renal cell carcinoma patients is associated with T cell dysfunction (English)

1 reference

30 July 2017

1 reference

9

Inderbir Gill

1 reference

30 July 2017

Soumika Biswas

1

1 reference

30 July 2017

Kaushik Biswas

2

1 reference

30 July 2017

Amy Richmond

3

1 reference

30 July 2017

Jennifer Ko

4

1 reference

30 July 2017

Sankar Ghosh

5

1 reference

30 July 2017

Matthew Simmons

6

1 reference

30 July 2017

Patricia Rayman

7

1 reference

30 July 2017

Brian Rini

8

1 reference

30 July 2017

Charles S Tannenbaum

10

1 reference

30 July 2017

James H Finke

11

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 October 2009

1 reference

30 July 2017

published in

Journal of Immunology

1 reference

30 July 2017

volume

183

1 reference

30 July 2017

issue

8

1 reference

30 July 2017

page(s)

5050-5058

1 reference

GM2 expression in renal cell carcinoma: potential role in tumor-induced T-cell dysfunction

30 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2890308

Glioblastomas induce T-lymphocyte death by two distinct pathways involving gangliosides and CD70.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2890308

Mechanisms and functional significance of tumour-induced dendritic-cell defects

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2890308

Gangliosides of organ-confined versus metastatic androgen-receptor-negative prostate cancer

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2890308

Serum total ganglioside level correlates with clinical course in melanoma patients after immunotherapy with therapeutic cancer vaccine

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2890308

Trafficking of ganglioside GD3 to mitochondria by tumor necrosis factor-alpha

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2890308

Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2890308

A novel ganglioside isolated from renal cell carcinoma

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2890308

Antisense TGF-beta2 immunotherapy for hepatocellular carcinoma: treatment in a rat tumor model

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2890308

Gangliosides induce cell apoptosis in the cytotoxic line CTLL-2, but not in the promyelocyte leukemia cell line HL-60.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2890308

Tumor-induced apoptosis of T lymphocytes: elucidation of intracellular apoptotic events

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2890308

Renal cell carcinoma-derived gangliosides suppress nuclear factor-kappaB activation in T cells

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2890308

Relationship of glycosyltransferases and mRNA levels to ganglioside expression in neuroblastoma and melanoma cells

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2890308

Brain-derived gangliosides regulate the cytokine production and proliferation of activated T cells.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2890308

Disialosyl galactosylgloboside as an adhesion molecule expressed on renal cell carcinoma and its relationship to metastatic potential

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2890308

Gangliosides of human melanoma: GM2 and tumorigenicity

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2890308

Detection of a tumour-associated ganglioside in plasma of patients with neuroblastoma

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2890308

Ganglioside antigens expressed by human cancer cells

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2890308

Enhanced expression of ganglioside GD3 in human and rat hepatocellular carcinoma cells and NIH 3T3 cells transfected with human tumor DNAs

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2890308

Immunosuppression by human gangliosides: I. Relationship of carbohydrate structure to the inhibition of T cell responses

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2890308

Sunitinib mediates reversal of myeloid-derived suppressor cell accumulation in renal cell carcinoma patients

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2890308

GM1 and tumor necrosis factor-alpha, overexpressed in renal cell carcinoma, synergize to induce T-cell apoptosis.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2890308

Tregs and rethinking cancer immunotherapy

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2890308

Characterization of a proapoptotic antiganglioside GM2 monoclonal antibody and evaluation of its therapeutic effect on melanoma and small cell lung carcinoma xenografts.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2890308

Arginase-producing myeloid suppressor cells in renal cell carcinoma patients: a mechanism of tumor evasion

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2890308

Degradation of NF-kappa B in T cells by gangliosides expressed on renal cell carcinomas

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2890308

Gangliosides from human melanoma tumors impair dendritic cell differentiation from monocytes and induce their apoptosis

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2890308

T cell-mediated immune responses in melanoma: implications for immunotherapy

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2890308

The role of Fas/FasL in immunosuppression induced by human tumors

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2890308

Selection of tumor antigens as targets for immune attack using immunohistochemistry: I. Focus on gangliosides.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2890308

Aberrant expression of gangliosides in human renal cell carcinomas.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2890308

Neuroblastoma-derived gangliosides inhibit dendritic cell generation and function

29 October 2018

1 reference

12 December 2020

Chimeric anti-ganglioside GM2 antibody with antitumor activity

1 reference

12 December 2020

Inhibition of immune cell proliferation and cytokine production by lipoprotein-bound gangliosides

1 reference

12 December 2020

Improved survival in stage III melanoma patients with GM2 antibodies: a randomized trial of adjuvant vaccination with GM2 ganglioside

1 reference

12 December 2020

Where have all the T cells gone? Mechanisms of immune evasion by tumors

1 reference

12 December 2020

Mechanisms of apoptosis in T cells from patients with renal cell carcinoma

1 reference

12 December 2020

Tumor gangliosides inhibit the tumor-specific immune response

1 reference

12 December 2020

Fas ligand is expressed on human squamous cell carcinomas of the head and neck, and it promotes apoptosis of T lymphocytes

1 reference

12 December 2020

Identifiers

DOI

10.4049/JIMMUNOL.0900259

1 reference

30 July 2017

1 reference

30 July 2017

1 reference